Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems

Bibliographic Details
Main Authors:	Elena Argento, Devon Christie, Lindsay Mackay, Cody Callon, Zach Walsh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Psychiatry
Subjects:	psychedelics mental health trauma COVID-19 pandemic psychedelic-assisted psychotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2021.716593/full

Similar Items

Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy
by: Victor Mocanu, et al.
Published: (2022-05-01)

Editorial: The psychotherapeutic framing of psychedelic drug administration
by: Maria Beckman, et al.
Published: (2023-01-01)

Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective
by: Winston De La Haye, et al.
Published: (2023-06-01)

Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
by: Mauro Cavarra, et al.
Published: (2022-06-01)

Transformative experience and informed consent to psychedelic-assisted psychotherapy
by: Edward Jacobs, et al.
Published: (2023-05-01)

On the need for metaphysics in psychedelic therapy and research
by: Peter Sjöstedt-Hughes, et al.
Published: (2023-03-01)

Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model
by: William Brennan, et al.
Published: (2022-06-01)

Commentary: Psychedelics and psychotherapy: Cognitive-behavioral approaches as default
by: John Burton, et al.
Published: (2022-09-01)

Psychedelic-Assisted Psychotherapy: When Two Traditions Meet
by: E. Frecska, et al.
Published: (2022-06-01)

Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
by: Modlin NL, et al.
Published: (2024-01-01)

The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences
by: Tomas Frymann, et al.
Published: (2022-05-01)

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
by: Lisa A. Page, et al.
Published: (2021-11-01)

Ethical and legal issues in psychedelic harm reduction and integration therapy
by: Brian Pilecki, et al.
Published: (2021-04-01)

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
by: Eduardo Ekman Schenberg
Published: (2018-07-01)

Back from the rabbit hole. Theoretical considerations and practical guidelines on psychedelic integration for mental health specialists
by: Jakub Greń, et al.
Published: (2023-10-01)

Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
by: Timothy I. Michaels, et al.
Published: (2018-07-01)

Commentary: On the need for metaphysics in psychedelic therapy and research
by: Katherine Cheung, et al.
Published: (2024-01-01)

Psychedelic integration: An analysis of the concept and its practice
by: Geoff J. Bathje, et al.
Published: (2022-08-01)

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default
by: David B. Yaden, et al.
Published: (2022-05-01)

Psychedelics and neonihilism: connectedness in a meaningless world
by: Patric Plesa, et al.
Published: (2023-08-01)

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress
by: Julia Ruixi Wang, et al.
Published: (2024-04-01)

Psychedelic Mystical Experience: A New Agenda for Theology
by: Ron Cole-Turner
Published: (2022-04-01)

Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
by: Phil Wolfson, et al.
Published: (2024-02-01)

Commentary: ARC: a framework for access, reciprocity and conduct in psychedelic therapies
by: Tahlia R. Harrison
Published: (2023-12-01)

Development of a digital intervention for psychedelic preparation (DIPP)
by: Rosalind G. McAlpine, et al.
Published: (2024-02-01)

Therapeutic use of psilocybin: Practical considerations for dosing and administration
by: Caroline A. MacCallum, et al.
Published: (2022-12-01)

“We don’t want to run before we walk”: the attitudes of Australian stakeholders towards using psychedelics for mental health conditions
by: Breanne E Kunstler, et al.
Published: (2023-09-01)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
by: Laura Orsolini, et al.
Published: (2018-05-01)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
by: Robert J. Sottile, et al.
Published: (2022-10-01)

Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
by: Raquel Bennett, et al.
Published: (2022-05-01)

MDMA for the treatment of misophonia, a proposal
by: Jadon Webb, et al.
Published: (2022-11-01)

ARC: a framework for access, reciprocity and conduct in psychedelic therapies
by: Meg J. Spriggs, et al.
Published: (2023-05-01)

Evidence versus expectancy: the development of psilocybin therapy
by: James J. Rucker

Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity
by: Lawrence G. Fischman
Published: (2022-09-01)

Psychedelics as a treatment for patients with post-traumatic stress disorder (PTSD)
by: Krzysztof Marcinkowski, et al.
Published: (2024-02-01)

Toward Synergies of Ketamine and Psychotherapy
by: David S. Mathai, et al.
Published: (2022-03-01)

Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders
by: Peter Oehen, et al.
Published: (2022-04-01)

New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy
by: Tehseen Noorani, et al.
Published: (2021-09-01)

LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01)

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
by: Muhammad Ishrat Husain, et al.
Published: (2023-07-01)